ProQR Therapeutics (PRQR) Current Leases (2021 - 2025)

ProQR Therapeutics (PRQR) has disclosed Current Leases for 5 consecutive years, with $1.8 million as the latest value for Q4 2025.

  • Quarterly Current Leases rose 7.4% to $1.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.8 million through Dec 2025, up 7.4% year-over-year, with the annual reading at $1.8 million for FY2025, 7.4% up from the prior year.
  • Current Leases hit $1.8 million in Q4 2025 for ProQR Therapeutics, up from $1.7 million in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $1.8 million in Q4 2025 to a low of $1.4 million in Q4 2022.
  • Historically, Current Leases has averaged $1.7 million across 5 years, with a median of $1.7 million in 2023.
  • Biggest five-year swings in Current Leases: dropped 19.36% in 2022 and later grew 22.72% in 2023.
  • Year by year, Current Leases stood at $1.8 million in 2021, then decreased by 19.36% to $1.4 million in 2022, then grew by 22.72% to $1.7 million in 2023, then decreased by 3.57% to $1.7 million in 2024, then grew by 7.4% to $1.8 million in 2025.
  • Business Quant data shows Current Leases for PRQR at $1.8 million in Q4 2025, $1.7 million in Q4 2024, and $1.7 million in Q4 2023.